While Wall Street traded in a subdued session marked by thin liquidity and low volumes following the Christmas market closure ...

The fourth-best-performing stock was wide-moat Novo Nordisk, which gained 8.96%. The 4-star stock has fallen 10.52% over the ...

The latest trading day saw Moderna (MRNA) settling at $32.29, representing a -7.48% change from its previous close.

Moderna, Inc. has rallied ~23%, but rated a Sell due to deteriorating fundamentals. Learn more about MRNA stock here.

Top large-cap gainers for Dec. 15–19 were led by Rivian, Moderna, and BioMarin, rising on product/software updates, vaccine ...

BioNTech SE (NASDAQ:BNTX) is one of the Stocks That Will Go To The Moon in 2026. On December 18, BioNTech SE (NASDAQ:BNTX) ...

Non-profit arm of the de-extinction company secures an additional $50 million, expands global projects and partnerships, and releases its inaugural Impact Report detailing progress in the fight ...

Tattoos have gained widespread popularity, with nearly one in three Americans having at least one. But beneath the colorful designs lurks a hidden journey. According to a new study, tattoo ink doesn’t ...

Moderna Inc. will get as much as $54.3 million for a late-stage trial of its bird flu vaccine in a sign of how outside groups ...

Shares of biotechnology company Moderna (NASDAQ:MRNA) jumped 4% in the morning session after the company announced it would ...

The Cybertruck, sycophantic AI, and humanoid robots all made this year’s list of the biggest technology failures.

A new study shows embryos and the uterus exchange extracellular vesicles, lipids, and signals that shape early pregnancy ...